Hydrogene Therapeutics Inc
Publicly observedHouston, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Houston | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Hydrogene Therapeutics Inc | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | RYZ8N8S6TNR5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant11 Sept 2026Publicly observed
NIH SBIR/STTR award: Developing Hydrodynamic Injection through Biliary System for the Treatment of Wilson's Disease
USD 1,097,036.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant10 Sept 2026Publicly observed
NIH SBIR/STTR award: Non-viral hydrodynamic gene therapy for life-long correction of hemophilia
USD 1,027,445.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.